After the Gavel · Washington · 2025–26 Session
SB5917

Washington Turned Its Prison Pharmacy Into a Free Abortion-Drug Program

What happens to a program when the state stops charging for it? You find out what it was really for.

In 2023, Washington used the one pharmacy license it already owned to stockpile abortion pills. The license belongs to the Department of Corrections, the agency that runs the prisons. The Governor directed it to buy 30,000 doses of mifepristone, about a three-year supply, for $1.27 million. The University of Washington picked up roughly 10,000 more. The doses arrived on March 31, 2023, and the state announced the purchase that April as an insurance policy against federal litigation that threatened access to the drug.

That was the stockpile. This year the legislature turned it into a distribution operation.

SB5917 rewrites the 2023 statute, RCW 72.09.780. Here is what the enrolled text actually does.

  1. It keeps the Corrections pharmacy's authority to acquire, possess, sell, deliver, and dispense abortion medications.
  2. It extends that authority to any person, whether or not the person is in state custody.
  3. It waives the wholesaler license that normally governs anyone distributing drugs in bulk.
  4. It directs the department to build a program that ships those drugs out, prioritizing bulk distribution to clinics and health care providers.
  5. It deletes the old requirement that the state recover its cost and charge a five-dollar-per-dose fee deposited to the general fund. In its place: the department "may but is not required to obtain any payment."

Read those five moves together and one of them tells you what the other four are for.

The Tell

The deleted fee is the tell. The 2023 law was cost-neutral by design. The state recovered what it spent and sent a small fee to the general fund. That single line tied the program to its own expense. Strike it, and the ceiling comes off. The state can now give abortion drugs away for free, in bulk, to any person, funded by every taxpayer. Nothing in the text caps the volume, the cost, or the number of recipients. The program grows to whatever the department decides to spend.

This matters because of who is now paying for it. A Washingtonian who believes an unborn child is a life does not get to opt out. There is no conscience accommodation in the bill. Their tax dollars fund the free distribution of the drugs, routed through the prison system, with the licensing check that governs every other bulk drug distributor waived by name.

Watch the trajectory, because it is the clearest part of the record. Authorize the stockpile in 2023. Adjust the authority in 2025. Remove cost recovery and open distribution to any person in 2026. That is three expansions in three consecutive law-years, each one written by the same coalition, each one broader than the last. A program that started as a quiet insurance policy is now an active subsidy. It did not drift there. It was walked there, one session at a time.

There is one more move worth naming. The bill carries an emergency clause, so it took effect immediately on March 14, 2026. An emergency clause does more than speed things up. It strips the people's ability to refer the act to the ballot. A significant expansion of state power, placed beyond the reach of the referendum the state constitution otherwise guarantees.

Supporters will call this access. Ask what the free version accesses that the cost-recovery version did not. The pills were already stockpiled. The state could already sell them. The only thing SB5917 adds is scale with no bill attached, and a check that used to be there, removed. When you stop charging for a thing and start prioritizing bulk shipment of it, you are not improving access.

You are running a subsidy, and you have decided the public should not see the invoice.

This is our read of the bill. We encourage you to read it yourself and reach your own conclusions. The sources are public and cited below.

Sources

© 2026 InPublic Systems - All Rights Reserved.

Legislative and policy intelligence for conservative advocacy organizations.

(425) 298-6627